SEC Form 4 · accession 0000874015-15-000072
IONIS PHARMACEUTICALS INC · IONS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
B Lynne Parshall
Officer — COO & Secretary · Director
Period of report
Jul 1, 2015
Accepted (ET)
Jul 2, 2015 · 6:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874015
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 1, 2015 | J | 71 | $48.586 | A | 8,143 | D | |
| Common StockF2 | Jul 1, 2015 | M | 6,218 | $10.29 | A | 14,361 | D | |
| Common StockF2 | Jul 1, 2015 | S | 6,218 | $57.561 | D | 8,143 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $10.29 | Jul 1, 2015 | M | 6,218 | D | Jan 3, 2015 | Jan 2, 2018 | Common Stock | 6,218 | 1,375 | D |
Explanation of responses
- F1Reporting 71 shares acquired under the Isis Pharmaceuticals, Inc. Amended and Restated 2000 Employee Stock Purchase Plan on July 1, 2015. These 71 shares may not be sold until January 2, 2016.
- F2Acquired as a result of exercising a stock option pursuant to a Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on 2/11/2015.